cycloheximide has been researched along with z-val-ala-asp(ome)-fluoromethylketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, D; Ch'en, IL; Cuny, GD; Degterev, A; Gerber, SA; Germscheid, M; Hedrick, SM; Hitomi, J; Korkina, O; Lugovskoy, A; Teng, X; Wagner, G; Yuan, C; Yuan, J | 1 |
| Cai, SX; Drewe, J; Guastella, J; Huang, JC; Kasibhatla, S; Tran, M; Tseng, B; Wang, Y; Woodward, R; Xue, D; Yang, W; Zhang, L | 1 |
2 other study(ies) available for cycloheximide and z-val-ala-asp(ome)-fluoromethylketone
| Article | Year |
|---|---|
Identification of RIP1 kinase as a specific cellular target of necrostatins.
Topics: Animals; Apoptosis; Imidazoles; Mice; Protein Kinase Inhibitors; Protein Kinases; Structure-Activity Relationship | 2008 |
MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Brain Ischemia; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Cycloheximide; Cysteine Proteinase Inhibitors; Dipeptides; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Female; HeLa Cells; Humans; Jurkat Cells; Liver; Male; Mice; Myocardial Infarction; Poly(ADP-ribose) Polymerases; Rats; Rats, Inbred F344; Tumor Necrosis Factor-alpha | 2003 |